• 한국식품위생안전성학회지
• /
• 제3권2호
• /
• pp.65-73
• /
• 1988

종래의 화학적, 생물학적 분석방법의 단점인 검출한도가 낮은점, 시료전처리의 복잡성, 비경제성 및 비 특이성 등을 극복하기 위해 monoclonal AB를 사용한 ELISA법으로 T-2 toxin 에 대해 특이성있는 새로운 분석법을 개발하여 다음과 같은 결과를 얻었다. 1. 종래의 GLC 및 GC-MS 분석법보다 간편하고 신뢰성이 높으며 검출한계가 0.1ppb인 고감도의 분석법을 개발하였다. 2. 본 분석법을 이용하여 Fusarium spp. 균의 T-2 생산유무를 단시간에 다량의 시료를 검색할 수 있었으며, data의 정확도가 GLC와 유사하며 GLC로는 검색할 수 없는 150ppb이하의 미량함유 시료에서도 T-2 toxin을 검색할 수 있었다. 3. 본 실험에 사용한 F. sporotichioides M-1-1 균주의 밀에 대한 최적 배양조건은 $24~27^{\circ}C$ 2주간임을 알았다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권1호
• /
• pp.237-241
• /
• 2012

Objective: Screening for colorectal cancer using guaiac-based fecal occult blood tests (gFOBT) is well established in Western populations, but is hampered by poor patient compliance due to the imposed dietary restrictions. Fecal immunochemical tests (FIT) do not require dietary restriction, but are more expensive than gFOBT and therefore restrict its use in developing countries in Asia. However, Asian diets being low in meat content may not require diet restriction for gFOBT to achieve equivalent results. The objective of this study was to evaluate and compare the validity and suitability of gFOBT and FIT or a combination of the two in screening for colorectal neoplasias without prior dietary restriction in an Asian population. Methods: Patients referred to the Endoscopic Unit for colonoscopy were recruited for the study. Stool samples were collected prior to bowel preparation, and tested for occult blood with both gFOBT and FIT. Dietary restriction was not imposed. To assess the validity of either tests or in combination to detect a neoplasm or cancer in the colon, their false positive rates, their sensitivity (true positive rate) and the specificity (true negative rate) were analyzed and compared. Results: One hundred and three patients were analysed. The sensitivity for picking up any neoplasia was 53% for FIT, 40% for gFOBT and 23.3% for the combination. The sensitivities for picking up only carcinoma were 77.8%, 66.7% and 55.5%, respectively. The specificity for excluding any neoplasia was 91.7% for FIT, 74% for gFOBT and 94.5% for a combination, whereas for excluding only carcinomas they were 84%, 73.4% and 93.6%. Of the 69 with normal colonoscopic findings, FOBT was positive in 4.3%, 23.2 %and 2.9% for FIT, gFOBT, or combination of tests respectively. Conclusion: FIT is the recommended method if we are to dispense with dietary restriction in our patients because of its relatively low-false positivity and better sensitivity and specificity rates.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권12호
• /
• pp.5111-5113
• /
• 2015

Background: To investigate the diagnostic and treatment methods for Chinese patients with gastrointestinal stromal tumor (GIST). Materials and Methods: From January 2004 to June 2014, patients diagnosed with primary GIST and treated by a single medical team in the Department of Digestive Disease of XuYi Hospital of Traditional Chinese Medicine were retrospectively recruited. Re-examination and follow-up was conducted regularly and abdominal enhanced CT, blood biochemistry and responses to surgery or imatinib were recorded. Results: A total of 15 patients were enrolled, including 9 male and 6 female patients, with an average age of 54 years (ranging from 32-81 years). The primary symptoms were abdominal uncomfortable in 5 patients, abdominal pain in 6 patients as well as nausea and vomiting in 4 patients. One patient was diagnosed with bowl obstruction at the first visit. All patients were treated with surgery, and tumor site was confirmed 1 esophagus, 6 stomach, 4 small bowel, and 4 colorectal and all patients were pathologically diagnosed with GIST. Immunochemical test positive for CD 117 was found 12 patients, and positive for CD 34 in7 patients. The median follow-up time was 24 months (range of 3-63). Three metastasis were confirmed 1.5, 2 and 2.6 years postoperatively. Three patients were treatment by imatinib postoperatively. Conclusions: Surgery remains the main treatment method for Chinese patients with GIST and imatinib could be feasible and safe for treating Chinese patients with GIST.

• Journal of Korean Neurosurgical Society
• /
• 제54권1호
• /
• pp.1-7
• /
• 2013

Objective : This study was undertaken in the belief that the atypical antipsychotic drug quetiapine could prevent apoptosis in the penumbra region following ischemia, taking into account findings that show 5-hydroxytryptamine-2 receptor blockers can prevent apoptosis. Methods : We created 5 groups, each containing 6 animals. Nothing was done on the K-I group used for comparisons with the other groups to make sure adequate ischemia had been achieved. The K-II group was sacrificed on the 1st day after transient focal cerebral ischemia and the K-III group on the 3rd day. The D-I group was administered quetiapine following ischemia and sacrificed on the 1st day while the D-II group was administered quetiapine every day following the ischemia and sacrificed on the 3rd day. The samples were stained with the immunochemical TUNEL method and the number of apoptotic cells were counted. Results : There was a significant difference between the first and third day control groups (K-II/K-III : p=0.004) and this indicates that apoptotic cell death increases with time. This increase was not encountered in the drug groups (D-I/D-II : p=1.00). Statistical analysis of immunohistochemical data revealed that quetiapine decreased the apoptotic cell death that normally increased with time. Conclusion : Quetiapine is already in clinical use and is a safe drug, in contrast to many substances that are used to prevent ischemia and are not normally used clinically. Our results and the literature data indicate that quetiapine could help both as a neuronal protector and to resolve neuropsychiatric problems caused by the ischemia in cerebral ischemia cases.

• Preventive Nutrition and Food Science
• /
• 제4권1호
• /
• pp.47-51
• /
• 1999

In order to evaluate the dietary regulation of cysteine sulfinic acid decarboxylase (EC 4.1.1.29) in cats, acitivity and protein content of CSAD were assessed in the liver and kidney of cats fed different levels of dietary protein, with and without taurine. Four groups of cats were fed one of the follow diets for 5 weeks ; 20% protein and taurine- free diet(LP0T) ; 20% protein and 0.15% taurine diet(LPNT) ; 60% protein and taurine-free diet(HP0T); and 60% protein and 0.15% taurine diet (HPNT). CSAD activity was determined in the liver and kidney of cats by measuring 14C2 released form [1-14C]-L cysteine sulfinic acid. CSAD protein was quantified using an immunochemical method. CSAD activity was extremely low in cat tissues, among which kidney showed the highest activity which was 0.118$\pm$0.050, and 0.377$\pm$0.056 nmol.min-1.mg soluble portein-1 iin animals fed LP0T and HP0T, respectively. Even though renal CSAD protein content was 18~55% of the hepatic CSAD protein content, renal CSAD acitivity was 1.3~6.5 times of the hepatic CSAD activity . Renal CSAD acitivities of cats fed 60% protein were about 1.6~3.2 times those of animals fed 2.% protein , and hepatic CSAD activity was not significantly affected by the dietary level of protein. Taurine depletion significantly elevated both hepatic and renal CSAD activities above the values for cats having normal taurine status most probably as an adaptive response.

• Journal of Chest Surgery
• /
• 제40권9호
• /
• pp.593-599
• /
• 2007

배경: 폐절제술이 우심실 기능에 미치는 영향과 BNP (brain natriuretic peptide)의 관계에 대해서는 아직 자세히 알려져 있지 않다. 본 연구에서는 폐절제술 후 변화하는 혈역학적 수치와 우심부전의 보상기전으로서 증가하는 BNP의 관계에 대해서 알아보고 BNP가 폐절제술 후의 우심부전의 지표가 될 수 있는지를 확인하고자 하였다. 대상 및 방법: 폐암으로 폐엽절제술과 전폐절제술을 시행한 12명의 환자에서 면역화학적 방법(Elecsys $1010^{(R)}$, Roche, Germany)을 이용하여 수술 전후의 NT-proBNP 수준을 측정하고, Swan-Ganz 카테터로 수술 전후에 혈역학적 지표를 측정하여 비교하였으며 수술 전후에 심초음파를 시행하여 우심실 및 좌심실압 등의 변화를 비교하였다. 통계처리는 SPSSWIN(version 11.5)를 이용한 Wilcoxon rank sum test와 linear regression을 이용하였다. 결과: NT-proBNP 수준은 수술 전과 비교하여 수술 후 6시간, 수술 후 1일과 2일, 3일, 7일째에 유의하게 증가하였다(p=0.003, 0.002, 0.002, 0.006, 0.004). Swan-Ganz 카테터를 통한 혈역학적 변수 중에서는 평균 폐동맥압이 수술 전과 비교하여 수술 직후와 수술 후 6시간, 수술 후 1일, 2일, 3일째에 유의하게 증가하였으며(p=0.002, 0.002, 0.006, 0.007, 0.008), 평균 우심실압력은 수술 직후와 수술 후 6시간, 수술 후 1일과 3일에서 유의하게 증가하였다(p=0.006, 0.009, 0.044, 0.032). 폐혈관저항지수[폐혈관저항지수=(평균폐동맥압-평균폐동맥쐐기압)/심박출계수]는 수술 후 6시간, 수술 후 2일에서 유의한 증가가 있었다(p=0.008, 0.028). 평균폐동맥압의 수술 후 변화와 NT-proBNP 변화를 회기분석하였을 때 수술 후 6시간에서 유의성이 있었으며(r=0.602, p=0.038) 이후에는 유의성이 없었다. 심초음파 결과는 수술 전후를 비교하여 유의성이 없었다. 결론: 폐절제술 후 6시간의 폐동맥압의 변화와 NT-proBNP의 변화가 유의성이 있었다. 따라서 폐절제술 후 NT-proBNP의 변화는 폐절제술 후 우심실의 조기 혈역학적 변화를 반영하는 척도가 될 수 있으리라 판단된다.